TGF-β signaling is pivotal for tissue development in normal cells and aberrant proliferation and EMT in cancer cells [29, 30], as a critical modulator of TGF-β signaling, the deregulation of TGFBR2 has the potential to affect a variety of biological processes of prostate cancer cells. The gene discussed is TGFBR2; the disease is prostate carcinoma.